| scholarly article | Q13442814 |
| P50 | author | Lori Walker | Q57438001 |
| P2093 | author name string | David A Fullerton | |
| Peter M Buttrick | |||
| P2860 | cites work | Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2 | Q28139921 |
| Transgenic mouse model of stunned myocardium | Q28142983 | ||
| Myosin heavy chain isoform expression in the failing and nonfailing human heart | Q28145777 | ||
| Effects of different expression and posttranslational modifications of myosin light chains on contractility of skinned human cardiac fibers | Q28189018 | ||
| Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins | Q28198289 | ||
| The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation | Q28208615 | ||
| Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction | Q28237729 | ||
| Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure | Q28271071 | ||
| Cardiac myofilament regulation by protein phosphatase type 1alpha and CapZ | Q28273888 | ||
| Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation | Q28294519 | ||
| Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation | Q28304945 | ||
| Cardiac myosin-binding protein-C phosphorylation and cardiac function | Q28584863 | ||
| Left ventricular and myocardial function in mice expressing constitutively pseudophosphorylated cardiac troponin I. | Q33822294 | ||
| Myosin isoforms, muscle fiber types, and transitions | Q33918690 | ||
| Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure | Q34122478 | ||
| Type 1 phosphatase, a negative regulator of cardiac function | Q34281889 | ||
| Cardiac plasticity | Q34764732 | ||
| Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support | Q36125213 | ||
| p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility | Q36869603 | ||
| Sarcomeric dysfunction in heart failure. | Q37022736 | ||
| Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes | Q37086451 | ||
| Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology | Q37276968 | ||
| Hypertension and diastolic heart failure | Q37623102 | ||
| The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments | Q38324753 | ||
| Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice | Q41248958 | ||
| Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heart | Q42478641 | ||
| Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2. | Q42480304 | ||
| Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. | Q42488512 | ||
| Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles | Q43541653 | ||
| Site-specific phosphorylation and point mutations of telokin modulate its Ca2+-desensitizing effect in smooth muscle | Q43603117 | ||
| Myosin light chain-actin interaction regulates cardiac contractility. | Q53012037 | ||
| Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. | Q53059138 | ||
| Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure | Q57396530 | ||
| Tissue procurement strategies affect the protein biochemistry of human heart samples | Q57455665 | ||
| Troponin I protein kinase C phosphorylation sites and ventricular function | Q57775275 | ||
| Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1 | Q64378890 | ||
| Force-pCa relation and troponin T isoforms of rabbit myocardium | Q68062809 | ||
| Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure | Q69888446 | ||
| Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure | Q70376386 | ||
| Mechanical properties of myocardium from hypertrophied rat hearts. A comparison between hypertrophy induced by senescence and by aortic banding | Q70522294 | ||
| Congestive heart failure: role of cross-bridge cycle kinetics | Q74591925 | ||
| Molecular mechanisms of myocardial remodeling | Q77918078 | ||
| Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure | Q79325476 | ||
| Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model | Q81653915 | ||
| Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology | Q82242423 | ||
| P433 | issue | 12 | |
| P921 | main subject | heart disease | Q190805 |
| phosphorylation | Q242736 | ||
| P304 | page(s) | H1644-50 | |
| P577 | publication date | 2013-04-05 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Contractile protein phosphorylation predicts human heart disease phenotypes | |
| P478 | volume | 304 |
| Q37622081 | Characterization and validation of new tools for measuring site-specific cardiac troponin I phosphorylation |
| Q38816583 | Contribution of Post-translational Phosphorylation to Sarcomere-Linked Cardiomyopathy Phenotypes. |
| Q92991260 | Exploring the Continuum of Hypertrophic Cardiomyopathy-From DNA to Clinical Expression |
| Q50598076 | Functional communication between PKC-targeted cardiac troponin I phosphorylation sites. |
| Q34726797 | Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics |
| Q37603413 | Phosphoproteome Discovery in Human Biological Fluids |
| Q28078785 | Phosphorylation of the regulatory light chain of myosin in striated muscle: methodological perspectives |
| Q46165841 | Sex differences in myosin heavy chain isoforms of human failing and nonfailing atria |
| Q38813273 | The neglected messengers: Control of cardiac myofilaments by protein phosphatases. |
| Q28293301 | Tropomyosin de-phosphorylation in the heart: what are the consequences? |
Search more.